Siyuan Wang

Siyuan Wang has a solid background in investment management and finance. They currently hold the position of Head of Investor Relations at Xing Pharmaceutical. Prior to this, Siyuan worked as an Investment Manager at Waihan Capital from September 2019 to May 2021. They also gained experience as an Associate in the Deals Traineeship Program at PwC from October 2017 to September 2019. Siyuan had internships at both Jaishi Capital Management Co. Ltd. and Baker & McKenzie LLP Shanghai Office, where they gained valuable experience in private equity analysis and transfer pricing management consulting, respectively.

Siyuan Wang obtained a Master's degree in Accounting from the University of Illinois Urbana-Champaign in 2018. Prior to that, from 2012 to 2016, Siyuan Wang attended Shanghai Jiao Tong University, where they earned a Bachelor of Science (B.S.) degree in Physics (SJTU Science Class). In addition, Siyuan Wang obtained certification as an AICPA Associate Member from the American Institute of Certified Public Accountants in October 2018.